Gideon Capital Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-7,335
Closed -$360K 416
2018
Q4
$360K Buy
7,335
+2,951
+67% +$168K 0.15% 216
2018
Q3
$272K Buy
+4,384
New +$267K 0.13% 262
2017
Q4
Sell
-7,531
Closed -$278K 322
2017
Q3
$278K Sell
7,531
-4,229
-36% -$151K 0.27% 166
2017
Q2
$453K Buy
11,760
+5,167
+78% +$189K 0.5% 56
2017
Q1
$225K Sell
6,593
-8,634
-57% -$284K 0.13% 338
2016
Q4
$500K Buy
+15,227
New +$494K 0.32% 88

Other funds holding EHC

Gideon Capital Advisors's EHC Position: Q1 2019 in Review

Gideon Capital Advisors sold out of Encompass Health (EHC) in Q1 2019, closing a stake of 7,335 shares — an estimated $360K sold.

Gideon Capital Advisors first reported a position in EHC in Q4 2016 and held it in 6 quarters. The position peaked at $500K in Q4 2016. 427 funds tracked by Wall St. Rank hold EHC as of Q1 2019.

  • Gideon Capital Advisors reported no remaining Encompass Health position as of Q1 2019 after selling out during the quarter.
  • Gideon Capital Advisors sold 7,335 Encompass Health shares in Q1 2019, an estimated $360K.
  • Gideon Capital Advisors first reported a position in Encompass Health in Q4 2016 and held it in 6 quarters.
  • Gideon Capital Advisors's Encompass Health position peaked at $500K in Q4 2016.
  • 427 funds tracked by Wall St. Rank held Encompass Health as of Q1 2019.

Based on Gideon Capital Advisors's 13F filing for Q1 2019, filed 14 May 2019.